• 1
    Devita VT Jr, Hellman S, Rosenberg SA. Cancer principles and practice of oncology, 5th ed. Philadelphia: Lippincott Williams & Wilkins, 1995; 105481.
  • 2
    Hirata K, Sato T, Mukaiya M, et al. Results of 1001 pancreatic resections for invasive ductal adenocarcinoma of the pancreas. Arch Surg 1997;132: 7716.
  • 3
    Van Der Bruggen P, Traversari C, Chomez P, et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991;254: 16437.
  • 4
    Kawakami Y, Eliyahu S, Sakaguchi K, et al. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J Exp Med 1994;180: 34752.
  • 5
    Robbins PF, El-Gamil M, Li YF, et al. A mutated β-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J Exp Med 1996;183: 118592.
  • 6
    Robbins PF, El-Gamil M, Li YF, et al. The intronic region of an incompletely spliced gp 100 gene transcript encodes an epitope recognized by melanoma-reactive tumor-infiltrating lymphocytes. J Immunol 1997;159: 3038.
  • 7
    Traversari C, Meazza R, Coppolecchia M, et al. IFN-γ gene transfer restores HLA-class I expression and MAGE-3 antigen presentation to CTL in HLA-deficient small cell lung cancer. Gene Ther 1997;4: 102935.
  • 8
    Shichijo S, Nakao M, Imai Y, et al. A gene encoding antigenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytes. J Exp Med 1998;187: 27788.
  • 9
    Nakao M, Shichijo S, Imaizumi T, et al. Identification of a gene coding for a new squamous cell antigen recognized by the CTL. J Immunol 2000;165: 256574.
  • 10
    Yang D, Nakao M, Shichijo S, et al. Identification of a gene coding for a protein possessing shared tumor epitopes capable of inducing HLA-A24-restricted cytotoxic T lymphocytes in cancer patients. Cancer Res 1999;59: 405663.
  • 11
    Gomi S, Nakao M, Niiya F, et al. A cyclophilin B gene encodes antigenic epitopes recognized by HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes. J Immunol 1999;163: 49945004.
  • 12
    Kawano K, Gomi S, Tanaka K, et al. Identification of a new endoplasmic reticulum-resident protein recognized by HLA-A24-restricted tumor infiltrating lymphocytes of lung cancer. Cancer Res 2000;60: 35508.
  • 13
    Harashima N, Tanaka K, Sasatomi T, et al. Recognition of the Lck tyrosine kinase as a tumor antigen by cytotoxic T lymphocytes of cancer patients with distant metastases. Eur J Immunol 2001;31: 32332.
  • 14
    Ito M, Shichijo S, Tsuda N, et al. Molecular basis of T cell-mediated recognition of pancreatic cancer cells. Cancer Res, 2001;61: 203846.
  • 15
    Ito M, Shichijo S, Miyagi Y, et al. Identification of SART3-derived peptides capable of inducing HLA-A2-restricted and tumor-specific CTLs in cancer patients with different HLA-A2 subtypes. Int J Cancer 2000;88: 6339.
  • 16
    Marchand M, Van Baren N, Weynants P, et al. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int J Cancer 1999;80: 21930.
  • 17
    Nestle OF, Alijagic S, Gilliet M, et al. 1998. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nature Med 1998;4: 32832.
  • 18
    Rosenberg SA, Yang JC, Schwartzentruber DJ, et al. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nature Med 1998;4: 3217.
  • 19
    Wang F, Bade E, Kuniyoshi C, et al. Phase I trial of a MART-1 peptide vaccine with incomplete freund's adjuvant for resected high-risk melanoma. Clin Cancer Res 1999;59: 405666.
  • 20
    Janeway CA, Travers P, Walport M, et al. Immuno biology, 4th ed. New York: Current Biology Publications & Garland Publishing, 1999: 3913.
  • 21
    Janeway CA, Travers P, Walport M, et al. Immuno biology, 4th ed. New York: Current Biology Publications & Garland Publishing, 1999: 5623.
  • 22
    Tanaka S, Tsuda N, Kawano K, et al. Expression of tumor-rejection antigens in gynecologic cancers. Jpn J Cancer Res 2000;91: 117784.
  • 23
    Sudo T, Kamikawaji N, Kimura A, et al. Difference in MHC class I self peptide repertoires among HLA-A2 subtypes. J Immunol 1995;155(10): 474956.
  • 24
    Imanishi T, Akaza T, Kimura A, et al. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: TsujiK, AizawaM, SasazukiT, eds. HLA 1991, vol. 1. Oxford: Scientific Publications, 1992. 1065.
  • 25
    Kammula US, Lee KH, Riker AI, et al. Functional analysis of antigen-specific T lymphocytes by serial measurement of gene expression in peripheral blood mononuclear cells and tumor specimens. J Immunol 1999;163: 686775.